Medications for Hypoparathyroidism
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hypoparathyroidism.
Found 2 Approved Drugs for Hypoparathyroidism
Calcitriol
Brand Names
Calcitrol, Rocaltrol, Vectical
Calcitriol
Brand Names
Calcitrol, Rocaltrol, Vectical
Form: Ointment, Injection, Capsule, Solution
Method of administration: Oral, Intravenous, Topical
FDA approval date: July 18, 2003
Classification: Vitamin D3 Analog
Predialysis Patients Calcitriol capsules re indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of.
Yorvipath
Generic Name
Palopegteriparatide
Yorvipath
Generic Name
Palopegteriparatide
Form: Injection
Method of administration: Subcutaneous
FDA approval date: August 09, 2024
Classification: Parathyroid Hormone Analog
YORVIPATH is indicated for the treatment of hypoparathyroidism in adults. YORVIPATH is a parathyroid hormone analog (PTH(1-34)) indicated for the treatment of hypoparathyroidism in adults. ( 1 ) Limitations of Use : Not studied for acute post-surgical hypoparathyroidism. ( 1 ) Titration scheme only evaluated in adults who first achieved an albumin-corrected serum calcium of at least.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances